Anna Gabriele Prado dos Santos

Mrs. Anna Gabriele Prado dos Santos

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2023 in Journal of Toxicology and Environmental Health, Part A
Verified
Journal Article
Closed access
AFAndressa Yuri Fujiike
Andressa Yuri Fujiike
LOLarissa Cristina Bastos de Oliveira
Larissa Cristina Bastos de Oliveira
Diego Luis RibeiroDiego Luis Ribeiro
Diego Luis Ribeiro
ÉPÉrica Romão Pereira
Érica Romão Pereira
NONádia Calvo Martins Okuyama
Nádia Calvo Martins Okuyama
Juliana Mara SerpeloniJuliana Mara Serpeloni
Juliana Mara Serpeloni
Docetaxel (DTX) is one of the chemotherapeutic drugs indicated as a first-line treatment against metastatic prostate cancer (mPCa). This study aimed to compare the impact of DTX on mPCa (DU-145) tumor cells cultured as 2D monolayers and 3D multicellular tumor spheroids (MCTS) in vitro. The cells were treated with DTX (1-96 mu M) at 24, 48, or 72 hr in cell viability assays (resazurin, phosphatase acid, and lactate dehydrogenase). Cell death was assessed with fluorescent markers and proliferation by clonogenic assay (2D) and morphology, volume, and integrity assay (3D). The cell invasion was determined using transwell (2D) and extracellular matrix (ECM) (3D). Results showed that DTX decreased cell viability in both culture models. In 2D, the IC50 (72 hr) values were 11.06 mu M and 14.23 mu M for resazurin and phosphatase assays, respectively. In MCTS, the IC50 values for the same assays were 114.9 mu M and 163.7 mu M, approximately 10-fold higher than in the 2D model. The % of viable cells decreased, while the apoptotic cell number was elevated compared to the control in 2D. In 3D spheroids, only DTX 24 mu M induced apoptosis. DTX (>= 24 mu M at 216 hr) lowered the volume, and DTX 96 mu M completely disintegrated the MCTS. DTX reduced the invasion of mPCa cells to matrigel (2D) and migration from MCTS to the ECM. Data demonstrated significant differences in drug response between 2D and 3D cell culture models using mPCa DU-145 tumor cells. MCTS resembles the early stages of solid tumors in vivo and needs to be considered in conjunction with 2D cultures when searching for new therapeutic targets.

16 September 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ASAndresa Hiromi Sakai
Andresa Hiromi Sakai
ÉPÉrica Romão Pereira
Érica Romão Pereira
ASAnna Gabriele Prado dos Santos
Anna Gabriele Prado dos Santos
DQDébora Hipólito Quadreli
Débora Hipólito Quadreli
LLLuan Lima
Luan Lima
Juliana Mara SerpeloniJuliana Mara Serpeloni
Juliana Mara Serpeloni
Background/Objectives: Urothelial bladder carcinoma (UBC) is one of the most prevalent malignancies worldwide, and efforts have intensified to identify molecular markers that improve the prognosis and reduce treatment costs. Among the regulators of tumor behavior, microRNAs (miRNAs) have emerged as promising biomarkers for cancer diagnoses and treatment. The modulation of miR-25-3p has been associated with pancreatic, colorectal, and lung cancers; its role in UBC remains poorly explored. In this study, we investigated the effects of miR-25-3p modulation in a high-grade and muscle-invasive bladder cancer (MIBC) cell line (T24), using in vitro functional assays and bioinformatics approaches. Results: Bioinformatics analyses using TCGA-BLCA datasets revealed that miR-25-3p is upregulated in tumor tissues compared to non-tumor tissues, prompting an investigation into its molecular targets and related pathways. The transfection of T24 cells with an miR-25-3p mimic and inhibitor led to respective overexpression (11.16-fold) and downregulation (-2.82-fold) compared to the negative control. Functionally, miR-25-3p overexpression increased cell proliferation, viability, and migration, while its inhibition decreased the cell migration capacity. A gene expression analysis revealed that miR-25-3p overexpression resulted in the downregulation of TP53, AIFM1, NFE2L2, TFRC, ACSL4, SLC7A11, and SLC3A2, whereas MMP9, MMP11, and GPX4 were upregulated, suggesting a role in both migration and ferroptosis regulation. In the inhibitor group, increased SLC3A2 and decreased MMP11 expression further supported this connection. Our results using an in vitro model for MIBC with the transfection of T24 cells suggest that miR-25-3p influences key pathways involved in oxidative stress and cell death, promoting a more aggressive tumor phenotype. Conclusions: The modulation of miR-25-3p impacts the behavior of T24 bladder cancer cells and may indicate its role in disease progression. Our results underscore the potential of miR-25-3p as a prognostic biomarker and support further studies considering its therapeutic relevance in managing high-grade and muscle-invasive bladder cancer.

23 September 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
CLCelina Yung-Ai Lin Lee
Celina Yung-Ai Lin Lee
ASAnna Gabriele Prado dos Santos
Anna Gabriele Prado dos Santos
ASAndresa Hiromi Sakai
Andresa Hiromi Sakai
EPErica Romão Pereira
Erica Romão Pereira
JKJulia Ayumi Ikeda Kawasaki
Julia Ayumi Ikeda Kawasaki
Juliana Mara SerpeloniJuliana Mara Serpeloni
Juliana Mara Serpeloni